Sodium–glucose cotransporter-2 inhibitors in heart failure patients across the range of body mass index: a systematic review and meta-analysis of randomized controlled trials
Anastasia Adamou(University of Thessaly), George Ntaios(Çevre, Şehircilik ve İklim Değişikliği Bakanlığı), Iliana Stamatiou(University Hospital of Alexandroupolis), Despoina Koukousaki(University of Minnesota), Ioannis Kyriakoulis(University of Thessaly), Wolfram Doehner(Deutsches Herzzentrum der Charité), Dimitrios Sagris(University of Liverpool), Ioannis Kardoutsos(University of Thessaly), David‐Dimitris Chlorogiannis(Mount Auburn Hospital)
Cited by 8
Related Papers
2023 ESC Guidelines for the management of endocarditis
|European Heart Journal|2023|1.6k
Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology
|European Journal of Preventive Cardiology|2020|924
Type 2 Diabetes Mellitus and Heart Failure: A Position Statement from the Heart Failure Association of the European Society of Cardiology
|European Journal of Heart Failure|2018|716